SOAT2 and aortic atherosclerosis: By using an antisense oligonucleotide targeting Soat2 mRNA (SOAT2 ASO), SOAT2 expression was knocked down in a liver-specific manner resulting in decreased LDL cholesteryl oleate and diminished aortic atherosclerosis development [20].